# Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study

Event ID: nev_01m212b06afs5tegzpqdrv9t62

Canonical: https://kleory.com/news/events/nev_01m212b06afs5tegzpqdrv9t62/

Occurred: 2026-09-08T17:21:30.681Z


